JACOB LORSUNG: Open Payments
NPI 1861022568 · DUBUQUE, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$788 in 47 payments from 11 companies in 2025. Trend: 2023 $1,189 · 2024 $975 · 2025 $788
Food & beverage: $646Education: $142
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $242 |
| UCB, Inc. | 13 | $166 |
| GENZYME CORPORATION | 4 | $111 |
| Novartis Pharmaceuticals Corporation | 2 | $58 |
| E.R. Squibb & Sons, L.L.C. | 2 | $58 |
| Organon LLC | 7 | $39 |
| ABBVIE INC. | 2 | $32 |
| Lilly USA, LLC | 1 | $28 |
| Arcutis Biotherapeutics, Inc. | 1 | $21 |
| Galderma Laboratories, L.P. | 1 | $20 |
Products named: TREMFYA, Bimzelx, DUPIXENT, Rhapsido, Sotyktu, EBGLYSS, VTAMA, Zoryve.
Industry payments across IA — which companies pay providers there.
